Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention. Helen Coffey speaks to the dentists warning that jabs could have a worrying im ...

Before buying into the Metsera story, it may be worth waiting for more and later-stage data, as the bar for success has been set high by Eli Lilly's tirzepatide and Novo Nordisk's semaglutide.

Semaglutide is available for private prescription for weight loss under the Wegovy brand, alongside two other GLP-1s: Mounjaro (a brand of tirzepatide ... loss of overall structure can impact ...

FROM sulphur burps to diarrhoea, we’re all familiar with the brutal side effects of fat jabs – but have you heard of ‘Ozempic feet’?  Ozempic, a medication originally used by ...

Lilly markets its dual GIP and GLP-1 receptor agonist, tirzepatide, as Mounjaro for T2D and Zepbound for obesity, while Novo Nordisk markets its semaglutide drugs as Ozempic for T2D and Wegovy for ...

Lilly currently sells the medicine tirzepatide as weight-loss drug Zepbound and diabetes treatment Mounjaro, both of which are administered by injection. Novo offers semaglutide injectables of ...

Results from the ESSENCE Phase III clinical trial published in the New England Journal of Medicine show treating patients with semaglutide ... treatment with the drug tirzepatide on muscle volume ...